LABCORP HOLDINGS INC (LH) Stock Fundamental Analysis

NYSE:LH • US5049221055

282.67 USD
+0.19 (+0.07%)
At close: Feb 20, 2026
282.67 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Fundamental Rating

5

LH gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. LH has only an average score on both its financial health and profitability. LH has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year LH was profitable.
  • LH had a positive operating cash flow in the past year.
  • In the past 5 years LH has always been profitable.
  • In the past 5 years LH always reported a positive cash flow from operatings.
LH Yearly Net Income VS EBIT VS OCF VS FCFLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

1.2 Ratios

  • With a decent Return On Assets value of 4.77%, LH is doing good in the industry, outperforming 77.23% of the companies in the same industry.
  • With a decent Return On Equity value of 10.17%, LH is doing good in the industry, outperforming 72.28% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 7.65%, LH is in the better half of the industry, outperforming 72.28% of the companies in the same industry.
  • LH had an Average Return On Invested Capital over the past 3 years of 6.71%. This is below the industry average of 9.04%.
  • The last Return On Invested Capital (7.65%) for LH is above the 3 year average (6.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.77%
ROE 10.17%
ROIC 7.65%
ROA(3y)3.77%
ROA(5y)5.87%
ROE(3y)8.25%
ROE(5y)12.11%
ROIC(3y)6.71%
ROIC(5y)8.38%
LH Yearly ROA, ROE, ROICLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • LH's Profit Margin of 6.28% is amongst the best of the industry. LH outperforms 83.17% of its industry peers.
  • LH's Profit Margin has declined in the last couple of years.
  • LH's Operating Margin of 10.87% is amongst the best of the industry. LH outperforms 80.20% of its industry peers.
  • LH's Operating Margin has declined in the last couple of years.
  • LH has a Gross Margin of 28.76%. This is comparable to the rest of the industry: LH outperforms 57.43% of its industry peers.
  • LH's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.87%
PM (TTM) 6.28%
GM 28.76%
OM growth 3Y-9.72%
OM growth 5Y-12.74%
PM growth 3Y-16.48%
PM growth 5Y-10.81%
GM growth 3Y-2.74%
GM growth 5Y-4.09%
LH Yearly Profit, Operating, Gross MarginsLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so LH is destroying value.
  • LH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for LH has been reduced compared to 5 years ago.
  • Compared to 1 year ago, LH has an improved debt to assets ratio.
LH Yearly Shares OutstandingLH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
LH Yearly Total Debt VS Total AssetsLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

2.2 Solvency

  • An Altman-Z score of 3.20 indicates that LH is not in any danger for bankruptcy at the moment.
  • LH has a Altman-Z score of 3.20. This is in the better half of the industry: LH outperforms 69.31% of its industry peers.
  • LH has a debt to FCF ratio of 4.69. This is a neutral value as LH would need 4.69 years to pay back of all of its debts.
  • With a decent Debt to FCF ratio value of 4.69, LH is doing good in the industry, outperforming 65.35% of the companies in the same industry.
  • A Debt/Equity ratio of 0.60 indicates that LH is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.60, LH is in line with its industry, outperforming 58.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 4.69
Altman-Z 3.2
ROIC/WACC0.93
WACC8.23%
LH Yearly LT Debt VS Equity VS FCFLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.42 indicates that LH should not have too much problems paying its short term obligations.
  • LH has a Current ratio (1.42) which is comparable to the rest of the industry.
  • A Quick Ratio of 1.23 indicates that LH should not have too much problems paying its short term obligations.
  • LH has a Quick ratio (1.23) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.23
LH Yearly Current Assets VS Current LiabilitesLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

4

3. Growth

3.1 Past

  • LH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.83%, which is quite good.
  • Measured over the past years, LH shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.22% on average per year.
  • LH shows a small growth in Revenue. In the last year, the Revenue has grown by 7.25%.
  • Measured over the past years, LH shows a decrease in Revenue. The Revenue has been decreasing by -0.04% on average per year.
EPS 1Y (TTM)12.83%
EPS 3Y-6.14%
EPS 5Y-7.22%
EPS Q2Q%17.97%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y5.55%
Revenue growth 5Y-0.04%
Sales Q2Q%5.6%

3.2 Future

  • LH is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.59% yearly.
  • The Revenue is expected to grow by 3.15% on average over the next years.
EPS Next Y9.56%
EPS Next 2Y9.34%
EPS Next 3Y9.51%
EPS Next 5Y6.59%
Revenue Next Year4.51%
Revenue Next 2Y4.74%
Revenue Next 3Y4.6%
Revenue Next 5Y3.15%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
LH Yearly Revenue VS EstimatesLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
LH Yearly EPS VS EstimatesLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 17.19 indicates a rather expensive valuation of LH.
  • Compared to the rest of the industry, the Price/Earnings ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 78.22% of the companies listed in the same industry.
  • LH is valuated rather cheaply when we compare the Price/Earnings ratio to 26.99, which is the current average of the S&P500 Index.
  • With a Price/Forward Earnings ratio of 15.69, LH is valued correctly.
  • 77.23% of the companies in the same industry are more expensive than LH, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 28.02. LH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 17.19
Fwd PE 15.69
LH Price Earnings VS Forward Price EarningsLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 62.38% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, LH is valued a bit cheaper than the industry average as 67.33% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 19.43
EV/EBITDA 12.99
LH Per share dataLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LH has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.8
PEG (5Y)N/A
EPS Next 2Y9.34%
EPS Next 3Y9.51%

4

5. Dividend

5.1 Amount

  • LH has a Yearly Dividend Yield of 1.03%.
  • Compared to an average industry Dividend Yield of 0.49, LH pays a better dividend. On top of this LH pays more dividend than 86.14% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.81, LH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.03%

5.2 History

  • LH has been paying a dividend for over 5 years, so it has already some track record.
  • LH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
LH Yearly Dividends per shareLH Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 1 2 3

5.3 Sustainability

  • 27.46% of the earnings are spent on dividend by LH. This is a low number and sustainable payout ratio.
DP27.46%
EPS Next 2Y9.34%
EPS Next 3Y9.51%
LH Yearly Income VS Free CF VS DividendLH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B
LH Dividend Payout.LH Dividend Payout, showing the Payout Ratio.LH Dividend Payout.PayoutRetained Earnings

LABCORP HOLDINGS INC

NYSE:LH (2/20/2026, 8:04:00 PM)

After market: 282.67 0 (0%)

282.67

+0.19 (+0.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-17
Earnings (Next)04-27
Inst Owners98.13%
Inst Owner Change5.2%
Ins Owners0.31%
Ins Owner Change1.35%
Market Cap23.43B
Revenue(TTM)13.95B
Net Income(TTM)876.50M
Analysts82.76
Price Target306.09 (8.29%)
Short Float %3.86%
Short Ratio4.48
Dividend
Industry RankSector Rank
Dividend Yield 1.03%
Yearly Dividend2.91
Dividend Growth(5Y)N/A
DP27.46%
Div Incr Years2
Div Non Decr Years2
Ex-Date02-27
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.79%
Min EPS beat(2)-1.84%
Max EPS beat(2)0.26%
EPS beat(4)2
Avg EPS beat(4)-0.15%
Min EPS beat(4)-1.84%
Max EPS beat(4)1.34%
EPS beat(8)4
Avg EPS beat(8)-0.03%
EPS beat(12)5
Avg EPS beat(12)-0.44%
EPS beat(16)6
Avg EPS beat(16)-0.53%
Revenue beat(2)0
Avg Revenue beat(2)-3.43%
Min Revenue beat(2)-4.07%
Max Revenue beat(2)-2.8%
Revenue beat(4)0
Avg Revenue beat(4)-3.25%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.56%
Revenue beat(12)0
Avg Revenue beat(12)-4.2%
Revenue beat(16)0
Avg Revenue beat(16)-9.31%
PT rev (1m)0.11%
PT rev (3m)-0.31%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.17%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)-0.21%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.01%
Valuation
Industry RankSector Rank
PE 17.19
Fwd PE 15.69
P/S 1.68
P/FCF 19.43
P/OCF 14.28
P/B 2.72
P/tB N/A
EV/EBITDA 12.99
EPS(TTM)16.44
EY5.82%
EPS(NY)18.01
Fwd EY6.37%
FCF(TTM)14.55
FCFY5.15%
OCF(TTM)19.79
OCFY7%
SpS168.3
BVpS103.98
TBVpS-21.3
PEG (NY)1.8
PEG (5Y)N/A
Graham Number196.12
Profitability
Industry RankSector Rank
ROA 4.77%
ROE 10.17%
ROCE 9.74%
ROIC 7.65%
ROICexc 7.92%
ROICexgc 25.61%
OM 10.87%
PM (TTM) 6.28%
GM 28.76%
FCFM 8.64%
ROA(3y)3.77%
ROA(5y)5.87%
ROE(3y)8.25%
ROE(5y)12.11%
ROIC(3y)6.71%
ROIC(5y)8.38%
ROICexc(3y)7.11%
ROICexc(5y)8.91%
ROICexgc(3y)25.11%
ROICexgc(5y)31.96%
ROCE(3y)8.54%
ROCE(5y)10.67%
ROICexgc growth 3Y-5.21%
ROICexgc growth 5Y-15.54%
ROICexc growth 3Y-1.42%
ROICexc growth 5Y-12.05%
OM growth 3Y-9.72%
OM growth 5Y-12.74%
PM growth 3Y-16.48%
PM growth 5Y-10.81%
GM growth 3Y-2.74%
GM growth 5Y-4.09%
F-Score8
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.6
Debt/FCF 4.69
Debt/EBITDA 2.34
Cap/Depr 63.79%
Cap/Sales 3.11%
Interest Coverage 250
Cash Conversion 74.66%
Profit Quality 137.59%
Current Ratio 1.42
Quick Ratio 1.23
Altman-Z 3.2
F-Score8
WACC8.23%
ROIC/WACC0.93
Cap/Depr(3y)72.83%
Cap/Depr(5y)71.26%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.64%
Profit Quality(3y)164.54%
Profit Quality(5y)144.06%
High Growth Momentum
Growth
EPS 1Y (TTM)12.83%
EPS 3Y-6.14%
EPS 5Y-7.22%
EPS Q2Q%17.97%
EPS Next Y9.56%
EPS Next 2Y9.34%
EPS Next 3Y9.51%
EPS Next 5Y6.59%
Revenue 1Y (TTM)7.25%
Revenue growth 3Y5.55%
Revenue growth 5Y-0.04%
Sales Q2Q%5.6%
Revenue Next Year4.51%
Revenue Next 2Y4.74%
Revenue Next 3Y4.6%
Revenue Next 5Y3.15%
EBIT growth 1Y33.23%
EBIT growth 3Y-4.71%
EBIT growth 5Y-12.77%
EBIT Next Year28.01%
EBIT Next 3Y13.66%
EBIT Next 5YN/A
FCF growth 1Y10.05%
FCF growth 3Y-6.47%
FCF growth 5Y-7.21%
OCF growth 1Y3.45%
OCF growth 3Y-5.69%
OCF growth 5Y-5.14%

LABCORP HOLDINGS INC / LH FAQ

What is the ChartMill fundamental rating of LABCORP HOLDINGS INC (LH) stock?

ChartMill assigns a fundamental rating of 5 / 10 to LH.


What is the valuation status for LH stock?

ChartMill assigns a valuation rating of 5 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.


What is the profitability of LH stock?

LABCORP HOLDINGS INC (LH) has a profitability rating of 6 / 10.


What is the valuation of LABCORP HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 17.19 and the Price/Book (PB) ratio is 2.72.


What is the expected EPS growth for LABCORP HOLDINGS INC (LH) stock?

The Earnings per Share (EPS) of LABCORP HOLDINGS INC (LH) is expected to grow by 9.56% in the next year.